Loading viewer...
investor_presentation
Format: PDF investor_presentation
This corporate presentation by RNXT outlines their late-clinical stage biopharmaceutical developments, focusing on pancreatic cancer therapies and future strategies.
Greatland Gold plc
FS Group Investor Presentation September 2024
investor_presentationinvestor_presentation
27 Pages
Ferrovie dello Stato Italiane S.p.A.